TCIM
KZR

TIAA CREF Investment Management’s Kezar Life Sciences KZR Stock Holding History

TIAA CREF Investment Management’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$271K Buy
+1,529
New +$301K ﹤0.01% 2810

Other funds holding KZR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

TIAA CREF Investment Management's KZR Position: Q1 2019 in Review

TIAA CREF Investment Management opened a new position in Kezar Life Sciences (KZR) in Q1 2019: 1,529 shares worth $271K. The stake represents ﹤0.01% of the portfolio and ranks #2810 among its holdings.

50 funds tracked by Wall St. Rank hold KZR as of Q1 2019.

  • TIAA CREF Investment Management held 1,529 shares of Kezar Life Sciences worth $271K as of Q1 2019.
  • Kezar Life Sciences was a new TIAA CREF Investment Management position in Q1 2019.
  • Kezar Life Sciences made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2810 holding.
  • 50 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.